Where’s The Beef? China Pushes For More Stringent Controls On Veterinary Drugs
This article was originally published in PharmAsia News
Executive Summary
A draft proposal by the Ministry of Agriculture comes at a time when several Big Pharma are pursuing opportunities in China’s veterinary market.
You may also be interested in...
Pfizer Inks Animal Health JV With Chinese Company Jilin Guoyuan
Pfizer Inc. announced a joint venture Sept. 8 with China's Jilin Guoyuan Animal Heatlh Company, Ltd. to develop, manufacture and distribute animal health vaccines in China
Sanofi Diversifies In China With $70 Million To Expand Production Capability For Animal Health Division Merial
SHANGHAI - Sanofi-Aventis' animal health division Merial Animal Health broke ground on a $70 million expansion of its Nanchang manufacturing site, six months after Sanofi CEO Chris Viehbacher said his company aims to diversify in China
Boehringer Ingelheim To Channel €100 Million Into Shanghai To Expand Production, Strengthen Quality Controls On APIs From China
SHANGHAI - Germany's Boehringer Ingelheim recently announced it would funnel a new €100 million ($ 150 million) investment into China to increase production capacity at its plant in the Shanghai Zhangjiang Hi-Tech Park and to introduce state-of-the-art quality control technology for active pharmaceutical ingredients sourced from China